 Connection
Spyridon Mastroyannis to United States
This is a "connection" page, showing publications Spyridon Mastroyannis has written about United States.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.073 |
|
|
|
-
Glaser GE, Lara OD, Pothuri B, Grimaldi CG, Prescott LS, Mastroyannis SA, Kim S, ElNaggar AC, Torres D, Conrad LB, McGree M, Weaver A, Huh WK, Cohn DE, Yamada SD, Fader AN. Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry study. Gynecol Oncol. 2022 11; 167(2):146-151.
Score: 0.017
-
Hermann CE, Nasioudis D, Mastroyannis SA, Latif NA, Haggerty AF, Giuntoli Ii RL, Cory L, Kim SH, Morgan MA, Ko EM. Utilization and outcomes of sentinel lymph node biopsy in patients with early stage vulvar cancer. Int J Gynecol Cancer. 2021 01; 31(1):40-44.
Score: 0.015
-
Nasioudis D, Mastroyannis SA, Latif NA, Ko EM. Trends in the surgical management of malignant ovarian germcell tumors. Gynecol Oncol. 2020 04; 157(1):89-93.
Score: 0.014
-
Nasioudis D, Wilson E, Mastroyannis SA, Sisti G, Haggerty AF, Ko EM, Latif NA. Increased Risk of Breast and Uterine Cancer Among Women With Ovarian Granulosa Cell Tumors. Anticancer Res. 2019 Sep; 39(9):4971-4975.
Score: 0.014
-
Nasioudis D, Wilson E, Mastroyannis SA, Latif NA. Prognostic significance of elevated pre-treatment serum CA-125 levels in patients with stage I ovarian sex cord-stromal tumors. Eur J Obstet Gynecol Reprod Biol. 2019 Jul; 238:86-89.
Score: 0.013
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|